PaCE CKD: A Multinational Survey of Financial Burden and Work Productivity in Patients with Chronic Kidney Disease and Caregivers
The indirect burden of CKD extends beyond clinical costs to include significant financial and work productivity impacts on patients and caregivers, with greater challenges for patients on dialysis. Strategies to prevent CKD progression appear warranted to alleviate burden on financial health and work productivity for patients and caregivers.
Authors
- R Correa-Rotter
- Juan José García Sánchez (ORCID: https://orcid.org/0000-0001-6546-7769)
- Hesham Elsayed (ORCID: https://orcid.org/0000-0001-9364-7409)
- Richard Hull
- Simon Fifer (ORCID: https://orcid.org/0000-0001-5221-0067)
- Steven J. Chadban (ORCID: https://orcid.org/0000-0002-0527-898X)
- Surendra Pentakota
- Ciro Esposito
- Helmut Reichel
- Mai-Szu Wu
- Thames Kularatne
Institutions
- AstraZeneca (United Kingdom) (GB)
- Ain Shams University (EG)
- University of Technology Sydney (AU)
- University of Pavia (IT)
- Royal Prince Alfred Hospital (AU)
- St George’s University Hospitals NHS Foundation Trust (GB)
- Istituti Clinici Scientifici Maugeri (IT)
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
- Nephrologisches Zentrum Villingen-Schwenningen (DE)
- AstraZeneca (France) (FR)
- AstraZeneca (Poland) (PL)
- Taipei Medical University (TW)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-12-24
- DOI
- https://doi.org/10.1007/s12325-025-03456-5
- Primary Topic
- Dialysis and Renal Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AstraZeneca